1. Ghosh, Shrestha, Raundhal, Mahesh, Myers, Samuel A, Petsko, Gregory A, Glimcher, Laurie H. 2021. Identification of RIOK2 as a master regulator of human blood cell development. In Nature immunology, 23, 109-121. doi:10.1038/s41590-021-01079-w. https://pubmed.ncbi.nlm.nih.gov/34937919/
2. Messling, Jan-Erik, Agger, Karl, Andersen, Kasper L, Lund, Anders H, Helin, Kristian. . Targeting RIOK2 ATPase activity leads to decreased protein synthesis and cell death in acute myeloid leukemia. In Blood, 139, 245-255. doi:10.1182/blood.2021012629. https://pubmed.ncbi.nlm.nih.gov/34359076/
3. Wang, Ya, Li, Kai, Mo, Shuangyang, Lu, Shunyu, Qin, Shanyu. 2024. Identification of common genes and pathways between type 2 diabetes and COVID-19. In Frontiers in genetics, 15, 1249501. doi:10.3389/fgene.2024.1249501. https://pubmed.ncbi.nlm.nih.gov/38699234/
4. Song, Yunnong, Li, Cheng, Jin, Lei, Yu, Rutong, Gao, Shangfeng. 2020. RIOK2 is negatively regulated by miR-4744 and promotes glioma cell migration/invasion through epithelial-mesenchymal transition. In Journal of cellular and molecular medicine, 24, 4494-4509. doi:10.1111/jcmm.15107. https://pubmed.ncbi.nlm.nih.gov/32125767/
5. Liu, Kun, Chen, Hong-Lin, Wang, Shuo, Yu, Kang-Jun, You, Qing-Sheng. 2016. High Expression of RIOK2 and NOB1 Predict Human Non-small Cell Lung Cancer Outcomes. In Scientific reports, 6, 28666. doi:10.1038/srep28666. https://pubmed.ncbi.nlm.nih.gov/27346559/
6. Liu, Kun, Chen, Honglin, You, Qingsheng, Li, Weinan, Gu, Mingming. 2018. miR‑145 inhibits human non‑small-cell lung cancer growth by dual-targeting RIOK2 and NOB1. In International journal of oncology, 53, 257-265. doi:10.3892/ijo.2018.4393. https://pubmed.ncbi.nlm.nih.gov/29749434/
智鼠故事 
